0000810084-14-000001.txt : 20140623
0000810084-14-000001.hdr.sgml : 20140623
20140603173428
ACCESSION NUMBER: 0000810084-14-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140430
FILED AS OF DATE: 20140603
DATE AS OF CHANGE: 20140603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC
CENTRAL INDEX KEY: 0000810084
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 931099680
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7180 SW SANDBURG STREET, SUITE 100
CITY: TIGARD
STATE: OR
ZIP: 97223
BUSINESS PHONE: 503-692-8001
MAIL ADDRESS:
STREET 1: 7180 SW SANDBURG STREET, SUITE 100
CITY: TIGARD
STATE: OR
ZIP: 97223
FORMER COMPANY:
FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Logomasini Mark
CENTRAL INDEX KEY: 0001480077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15360
FILM NUMBER: 14888637
MAIL ADDRESS:
STREET 1: 20245 SW 95TH AVENUE
CITY: TUALATIN
STATE: OR
ZIP: 97062
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-04-30
0
0000810084
BIOJECT MEDICAL TECHNOLOGIES INC
BJCT
0001480077
Logomasini Mark
7180 SW SANDBURG STREET, SUITE 100
TIGARD
OR
97223
1
1
1
0
President and CEO
Series I Preferred Stock
0.075
2014-04-30
4
P
0
8287467
0.075
A
2014-04-30
Common Stock
8287467
13524753
I
SEP
No expiration date.
Holdings: 11,173 shares of Series H Preferred Stock convertible into 3,192,286 shares of Common Stock. 62,156 shares of Series I Preferred Stock convertible into 8,287,416 shares of Common Stock held indirectly in SEP Fund. Option for 45,000 shares of Common Stock at $0.15 expiring June 9, 2017 and Option for 2,000,000 shares of Common Stock at $0.06 expiring February 14, 2023.
//Christine M. Farrell Attorney-in-Fact for Mark Logomasini//
2014-06-03